PHARMAC - Latest News [Page 2]
New Medicine And An Easier Renewal Process Proposed For People With ADHD
Thursday, 12 September 2024, 12:23 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is asking for feedback on two changes for people with attention deficit hyperactivity disorder (ADHD) - a new medicine, and changes to the renewal criteria. Pharmac is proposing: to fund lisdexamfetamine – known ... More >>
Pharmac Proposes To Widen Access To Medicine Used In The Treatment Of Heart Failure
Tuesday, 20 August 2024, 11:41 am | PHARMAC
Pharmac is consulting on plans to widen access to empagliflozin, a medicine used in the treatment of chronic heart failure that would benefit more than 18,000 people in the first year of funding. More >>
Pharmac Indicates Interest In Funding Cancer Treatment Bevacizumab
Friday, 9 August 2024, 10:37 am | PHARMAC
“Today, we have issued a Future Procurement Opportunity (FPO) for the cancer treatment bevacizumab,” says Pharmac’s Chief Medical Officer, Dr David Hughes. More >>
Significant Step Forward Proposed For Bowel Cancer
Monday, 5 August 2024, 11:07 am | PHARMAC
Public consultation has opened on Pharmac’s proposal to fund cetuximab (branded as Erbitux) for a type of bowel cancer where the cancer is located on the left side of the bowel and has spread to other parts of the body. More >>
Pharmac Closes Inactive Medicine Applications For Greater Clarity
Thursday, 1 August 2024, 2:27 pm | PHARMAC
Chief Executive Sarah Fitt says closing these applications is an important part of ensuring Pharmac’s work is transparent and easy to understand. More >>
Pharmac Opens Consultation On Oestradiol Gel
Thursday, 25 July 2024, 11:35 am | PHARMAC
Pharmac’s Director of Equity and Engagement Dr Nicola Ngawati says that if approved, more than 18,000 people would benefit in the first year of funding. More >>
More Funded Nutritional Supplements On The Way
Friday, 19 July 2024, 9:25 am | PHARMAC
Pharmac – Te Pātaka Whaioranga is funding more nutritional supplements for people living with inherited metabolic diseases. More >>
Pharmac Proposes To Widen Access To Urinary Tract Infection Treatment And Fund A New Epilepsy Treatment
Thursday, 18 July 2024, 1:06 pm | PHARMAC
Pharmac would like to hear from people who have experienced urinary tract infections or epilepsy, their whānau, clinicians and others in the health sector about the proposed eligibility criteria for both of these medicines. More >>
Pharmac Proposal To Increase Access To Five Medicines For Cancer And Other Health Conditions
Friday, 12 July 2024, 11:16 am | PHARMAC
Pharmac – Te Pātaka Whaioranga is looking to increase access to five medicines for a number of cancers, including kidney and lung cancers, and other health conditions. More >>
Over 6,000 People Will Benefit From Pharmac Funding Proposal If Approved
Wednesday, 10 July 2024, 11:40 am | PHARMAC
Pharmac – Te Pātaka Whaioranga plans to widen access to seven medicines benefitting over 6,000 people within the first 12 months of funding. More >>
Pharmac Opens First Consultation For Cancer Medicines After Funding Boost
Friday, 5 July 2024, 11:20 am | PHARMAC
Pharmac – Te Pātaka Whaioranga is looking to widen access to four medicines as part of the first public consultation following the budget boost. More >>
Multiple Myeloma Treatments Available To More People
Tuesday, 2 July 2024, 1:33 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is making more treatment options available for people with multiple myeloma and other blood disorders. “From 1 August, we’re widening access to lenalidomide and we’re also funding pomalidomide for the first ... More >>
Funding Boost Means More Medicines For More New Zealanders
Monday, 24 June 2024, 4:35 pm | PHARMAC
Pharmac welcomes the Government’s funding boost which will see about 175,000 more people receiving the medicines they need in the first year. More >>
More Funded Nutritional Supplements On The Cards For People With Inherited Metabolic Diseases
Thursday, 20 June 2024, 2:13 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is proposing to fund more nutritional supplements for people with inherited metabolic diseases and make them available to people closer to home. More >>
Pharmac Improves Access To Breast Cancer Treatments
Tuesday, 18 June 2024, 2:13 pm | PHARMAC
From 1 July, ribociclib (branded as Kisqali) will be funded for a form of advanced breast cancer known as HR-positive HER2-negative locally advanced or metastatic breast cancer. Palbociclib (branded as Ibrance) has been funded for this type of breast ... More >>
Pharmac Considering Feedback On Diabetes CGMs Funding Proposal
Tuesday, 21 May 2024, 11:13 am | PHARMAC
Pharmac will host an online information session in a fortnight to talk about the process of developing the funding proposal and provide an update on Pharmac’s next steps, including engagement with clinicians, consumers and suppliers. More >>
More Treatment Options Proposed For People With Multiple Myeloma And Myelodysplastic Syndrome
Tuesday, 23 April 2024, 1:16 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is proposing to fund more treatments for people with a type of blood cancer, multiple myeloma, and some people with a blood cell disorder, myelodysplastic syndrome. More >>
Pharmac Simplifies Access To A Medicine For The Rare Disorder, Wilson Disease
Friday, 12 April 2024, 2:05 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is making it easier for people with Wilson disease to get the medicine they need. From 1 May, trientine will be listed on the Pharmaceutical Schedule. At the moment people access it through one of Pharmac’s exceptional circumstances ... More >>
Pharmac Seeking Bids From Suppliers To Fund Another Type Of Hormone Replacement Therapy
Friday, 5 April 2024, 10:05 am | PHARMAC
“Pharmac is looking to fund a new type of oestradiol treatment without restrictions,” says Dr David Hughes, Pharmac’s Director Advice and Assessment/Chief Medical Officer. More >>
Pharmac Asking For Feedback On A Funding Proposal To Change The Lives Of 18,000 New Zealanders With Type 1 Diabetes
Thursday, 28 March 2024, 1:30 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga wants to hear what people think of a funding proposal for continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables. “We’ve reached provisional agreements with suppliers to provide funded CGMs, ... More >>